The market of medicines in new members of European Union with population of 75 million people totaled in € 7 billions. The product patents were implemented during 1990’s in these countries. Patent protection is a key concern for research - based industry in unified market. In central and Eastern European markets the generics make about 70% of all medicines prescribed. The novelty on the market are “authorized generics”.
Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.
Feb 18, 2020
Dec 6, 2019
|The pharmaceutical industry, innovation, generics and competitiveness in the context of EU Enlargement||Feb 18, 2020|
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Twardowska, Aleksandra Twardowski, Tomasz
Nowak, Jacek K.
Institute of Bioorganic Chemistry PAS Committee on Biotechnology PAS
Szewczyk, Krzysztof W.